BriMindInvest Logo

Welltower Inc. (WELL) Stock Analysis 2026

Real EstateREIT - Healthcare Facilities
$236.92
as of 2026-08-07

BriMind AI Score

Proprietary
54
Neutral
Price CAGR
15.6%
1Y Return
+41.0%
Analyst Upside
+7.7%
Rev Growth
39.1%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$307.14+29.6% potential
Bear Case
$180.02
Bull Case
$357.29
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

WELL Revenue & Profitability Breakdown

This chart shows how WELL's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$12.76B
Cost of Revenue
-$7.71B
Gross Profit
$5.05B39.6% margin
Operating Expenses
-$2.94B
Operating Income
$2.11B16.6% margin
Tax & Other
-$563.0M
Net Income
$1.55B12.1% margin
Gross Margin
39.6%
Operating Margin
16.6%
Net Margin
12.1%
EBITDA Margin
36.9%

Key Financial Metrics

A snapshot of the company's valuation, growth, profitability, and financial health. Key things to look at: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business — companies with strong FCF can buy back shares, pay dividends, or invest; Debt/Equity shows how leveraged the company is (high debt can be risky); Return on Equity tells you how efficiently the company generates profit from shareholders' money.

Market Cap
$168.93B
Enterprise Value
$115.14B
P/E (Trailing)
105.13
P/E (Forward)
71.58
EV / EBITDA
36.51
Price / Sales
11.81
Price / Book
2.97
Revenue
$12.76B
Revenue Growth
39.1%
Earnings Growth
35.6%
EBITDA
$3.15B
Gross Margin
39.6%
Operating Margin
16.6%
Net Margin
12.1%
Return on Equity
3.8%
Return on Assets
0.8%
Free Cash Flow
$2.76B
Total Cash
$3.50B
Total Debt
$17.01B
Debt / Equity
41.38
Current Ratio
1.32
Quick Ratio
0.95
Beta
0.76
Dividend Yield
1.5%
Payout Ratio
132.7%
Book Value / Share
$62.15

Wall Street Analyst Consensus

Professional analysts at investment banks set 12-month price targets after researching the company's earnings, competitive position, and industry trends. Strong Buy / Buy means the majority expect meaningful upside. Hold means analysts see fair value near the current price — not a sell signal, but limited near-term upside expected. The mean target is the average of all analyst price targets; the range shows where the most optimistic and most cautious analysts stand.

Consensus RatingBuy(20 analysts)
SellStrong Buy
Low Target$145.00-38.8%
Mean Target$252.41+6.5% upside
High Target$240.00+1.3%

Intrinsic Value Estimates for WELL

Intrinsic value is what a stock is truly worth based on the company's fundamentals — independent of what the market currently prices it at. We use multiple models because no single formula is perfect: each captures different aspects of a business. If multiple models agree the stock is undervalued, that convergence is a stronger signal. A stock trading well below its intrinsic value may be a bargain; one far above may carry more risk.

DCF Model (10yr)
$88.51
-62.6% vs current
Discounts 10 years of projected free cash flow back to today's dollars (5% growth, 10% discount rate). Best for companies generating consistent cash.
Fair Value Range
$88.51 – $88.51
Average Estimate
$88.51
Potential Downside
-62.6%

⚠️ Intrinsic value estimates use simplified models (Graham, DCF, P/E) and conservative assumptions. They should be used as one input among many — not as sole buy/sell guidance. For advanced analysis, see the full platform.

Compare WELL with Peers

WELL vs VTRWelltower vs Ventas — Which Healthcare REIT Wins?
CTRE vs WELLCareTrust REIT vs Welltower — Small vs Large Healthcare

Unlock the Full WELL Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
← Back to Home · Browse All Stock Analysis

We use cookies to keep you signed in and to understand how people use our site (Google Analytics). You can accept all cookies or limit them to what's strictly necessary. Privacy policy